Martin KE, Hammer Q, Perica K, Sadelain M, Malmberg KJ(2024) Engineering immune-evasive allogeneic cellular immunotherapies Nat Rev Immunol(in press) DOI 10.1038/s41577-024-01022-8, PubMed 38658708
Lund T, Gundesen MT, Juul Vangsted A, Helleberg C, Haukås E, Silkjær T, Asmussen JT, Manuela Teodorescu E, Amdi Jensen B, Schmidt Slørdahl T, Nahi H, Waage A, Abildgaard N, Schjesvold F, Nordic Myeloma Study Group(2024) In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease Blood Cancer J, 14(1), 65 DOI 10.1038/s41408-024-01046-2, PubMed 38622134
Casey NP, Kleinmanns K, Forcados C, Gelebart PF, Joaquina S, Lode M, Benard E, Kaveh F, Caulier B, Helgestad Gjerde C, García de Jalón E, Warren DJ, Lindemann K, Rokkones E, Davidson B, Myhre MR, Kvalheim G, Bjørge L, McCormack E, Inderberg EM, Wälchli S(2024) Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16 J Immunother Cancer, 12(4) DOI 10.1136/jitc-2023-008179, PubMed 38604812